Annual Review of Cancer Biology

Papers
(The TQCC of Annual Review of Cancer Biology is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Distinct Essentiality of the Mitochondrial Respiratory Chain in Proliferating Cells In Vivo87
Advances in Therapies Targeting Inhibitory Checkpoint Receptors: TIGIT, LAG-3, and Beyond57
YAP, TAZ, and Hippo-Dysregulating Fusion Proteins in Cancer32
Targeting Solid Tumors with Bispecific T Cell Engager Immune Therapy29
Immune Cell Metabolism and Immuno-Oncology29
Natural and Engineered Cytokines as Cancer Therapeutics29
Allogeneic CAR T Cell Therapy for Cancer26
They Contain Multitudes: The Diverse Roles of CD4+ T Cells in Cancer Immunity24
Caught in a Web: Emerging Roles of Neutrophil Extracellular Traps in Cancer24
Cancer Genomic Rearrangements and Copy Number Alterations from Errors in Cell Division23
Therapeutic Discovery for Chromatin Complexes: Where Do We Stand?22
Beyond Mice and Men: Alternative Vertebrate and Invertebrate Models in Cancer Biology22
Road Map to Defeat Pancreatic Cancer21
Stalled CARs: Mechanisms of Resistance to CAR T Cell Therapies19
Engineering Cancer with Next-Generation Genome Editing Tools19
Cancer Dependency Map: Past and Present19
Gut Microbiota in Colorectal Cancer: Associations, Mechanisms, and Clinical Approaches18
Rationales for Combining Therapies to Treat Cancer: Independent Action, Response Correlation, and Collateral Sensitivity Versus Synergy17
The Effects of Clonal Heterogeneity on Cancer Immunosurveillance14
An Erratic Path Toward Discovery13
Strategies for Heating Up Cold Tumors to Boost Immunotherapies12
Reinventing Radiobiology in the Light of FLASH Radiotherapy12
Engineering the Immune Microenvironment into Organoid Models12
0.085137128829956